GBFG
ATNM icon

Gerald Baker Financial Group’s Actinium Pharmaceuticals ATNM Stock Holding History

Gerald Baker Financial Group’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2K Hold
22,691
– – 0.01% 126
2026
Q1 		$22.6K Buy
+22,691
New +$27K 0.01% 114

Other funds holding ATNM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Gerald Baker Financial Group's ATNM Position: Q2 2026 in Review

Gerald Baker Financial Group held its Actinium Pharmaceuticals (ATNM) position steady in Q2 2026 at 22,691 shares worth $22.2K. The position accounts for 0.01% of the portfolio, ranked #126.

Gerald Baker Financial Group first reported a position in ATNM in Q1 2026 and has held it in 2 quarters since. The position peaked at $22.6K in Q1 2026. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • Gerald Baker Financial Group held 22,691 shares of Actinium Pharmaceuticals worth $22.2K as of Q2 2026.
  • Gerald Baker Financial Group left its Actinium Pharmaceuticals share count unchanged in Q2 2026.
  • Actinium Pharmaceuticals made up 0.01% of Gerald Baker Financial Group's portfolio in Q2 2026, its #126 holding.
  • Gerald Baker Financial Group first reported a position in Actinium Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Gerald Baker Financial Group's Actinium Pharmaceuticals position peaked at $22.6K in Q1 2026.
  • 47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Gerald Baker Financial Group's 13F filing for Q2 2026, filed 3 Aug 2026.